Home › Trial NCT02655601
Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001
- Trial IDNCT02655601
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorBioMimetix JV, LLC
- Enrollment177
- Start date2018-09-25
- ConditionsHigh Grade Glioma · Astrocytoma, Grade III · Glioblastoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.